Vitama S.A.

Manufacture of pharmaceutical preparations

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2012-05-10
Share capital
30,476,100.00 PLN
Registered address
Powsińska 106, 02-903 Warszawa, Poland
Website

Financials

Revenue history (in m)

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 425 days for 2020). 2 of 5 audited by a statutory auditor.

  • 2023not filed
  • 202221/08/2023
  • 202114/12/2022
  • 202014/12/2022
  • 201907/04/2021
  • 201813/02/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.

Sector · Manufacturing7,254 / 33,822
Top 21%
Voivodeship · Mazowieckie12,760 / 142,204
Top 9.0%
Country · Poland45,161 / 496,474
Top 9.1%

Results vs industry

Revenue
This companyUSD 4.29mMedianUSD 913.43kAverageUSD 25.82m
Net profit
This companyUSD 826.50kMedianUSD 14.22kAverageUSD 2.77m
Operating costs
This companyUSD 3.35mMedianUSD 846.99kAverageUSD 21.42m
Assets
This companyUSD 21.39mMedianUSD 897.46kAverageUSD 31.52m

Website technology

Website
  • WordPress

Trademarks

The company holds 4 active trademarks registered with the Polish Patent Office. 17 marks have expired or were not registered. The first mark was filed in 2013.

MarkNumberClassesStatusProtected until
NASOPRONAL (word)Z.5139325Protected May 25, 2030
AZYPRONAL (word)Z.5139265Protected May 25, 2030
TRANSBUPREMAX (word)Z.4676295Protected Feb 15, 2027
BEHISTEP (word)Z.4372515Protected Dec 24, 2034
VITAMA NATURE Z.5478765, 35Proceedings discontinued –
MarkProtected until
NASOPRONAL (word)May 25, 2030
AZYPRONAL (word)May 25, 2030
TRANSBUPREMAX (word)Feb 15, 2027
BEHISTEP (word)Dec 24, 2034
VITAMA NATURE –

Authorized Representatives

Marek Kluczny age 69 – President of the Management Board

Manner of representation

Each member of the management board acting independently

Supervisory board

Andrzej Kosman age 53 – Supervisory Board Member
Ewa Bożena Lubicz-Nowicka age 71 – Supervisory Board Member
Marcin Kaznowski age 50 – Supervisory Board Member

Beneficial owners

Person

Subsidiaries

NameStake
Elopharm sp. z o.o.
50%

Bank accounts

Was a VAT taxpayer from 2012-09-01 to 2026-08-04.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

8 closed proceedings recorded in KRZ history.

Registration dateProceeding typeStatus
Mar 31, 2026
Discontinued enforcement proceedings
Closed
Mar 31, 2026
Discontinued enforcement proceedings
Closed
May 31, 2025
Discontinued enforcement proceedings
Closed
Dec 23, 2024
Discontinued enforcement proceedings
Closed
Dec 12, 2024
Discontinued enforcement proceedings
Closed

MSiG notices

Publication dateEvent
May 19, 2022Call to creditors

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
Regional investment aid
–

Competitors

Name
Aristo Pharma sp. z o.o.
Orifarm Healthcare sp. z o.o.
Fortis Pharmaceuticals sp. z o.o.
Ethifarm sp. z o.o. + limited partnership
Adpharma sp. z o.o.
Neupharm sp. z o.o.
Cosma S.A.
Elanda Pharma sp. z o.o.
Solinea Pharmaceuticals sp. z o.o.
Goodwill Pharma Polska sp. z o.o.

Change history

DateEvent
2024-08-30Address change
2022-11-30Share capital increase
2022-09-28Share capital reduction
2017-02-07Share capital increase
2016-11-29Share capital increase

FAQ

Last updated: 2026-10-27